...
首页> 外文期刊>Clinical journal of the American Society of Nephrology: CJASN >Hospitalizations following living donor nephrectomy in the United States
【24h】

Hospitalizations following living donor nephrectomy in the United States

机译:在美国进行活体供体肾切除术后的住院治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Background and objectives: Living donors represented 43% of United States kidney donors in 2012. Although research suggests minimal long-term consequences of donation, few comprehensive longitudinal studies for this population have been performed. The primary aims of this study were to examine the incidence, risk factors, and causes of rehospitalization following donation. Design, setting, participants, & measurements: State Inpatient Databases (SID) compiled by the Agency for Healthcare Research and Quality were used to identify living donors in four different states between 2005 and 2010 (n=4524). Multivariable survival models were used to examine risks for rehospitalization, and patient characteristics were compared with data from the Scientific Registry of Transplant Recipients (SRTR). Outcomes among patients undergoing appendectomy (n=200,274), cholecystectomy (n=255,231), and nephrectomy for nonmetastatic carcinoma (n=1314) were contrasted. Results: The study population was similar to United States donors (for SRTR and SID, respectively: mean age, 41 and 41 years; African Americans, 12% and 10%; women, 60% and 61%). The 3-year incidence of rehospitalization following donation was 11% for all causes and 9% excluding pregnancy-related hospitalizations. After censoring of models for pregnancy-related rehospitalizations, older age (adjusted hazard ratio [AHR], 1.02 per year; 95% confidence interval [95% CI], 1.01 to 1.03), African American race (AHR, 2.16; 95% CI, 1.54 to 3.03), depression (AHR, 1.88; 95% CI, 1.12 to 3.14), hypothyroidism (AHR, 1.63; 95% CI, 1.06 to 2.49), and longer initial length of stay were related to higher rehospitalization rates among donors. Compared with living donors, adjusted risks for rehospitalizations were greater among patients undergoing appendectomy (AHR, 1.58; 95% CI, 1.42 to 1.75), cholecystectomy (AHR, 2.25; 95% CI, 2.03 to 2.50), and nephrectomy for nonmetastatic carcinoma (AHR, 2.95; 95% CI, 2.58 to 3.37). Risks for rehospitalizations were higher among African Americans than whites in each of the surgical groups. Conclusions: The SID is a valuable source for evaluating characteristics and outcomes of living kidney donors that are not available in traditional transplant databases. Rehospitalizations following donor nephrectomy are less than seen with other comparable surgical procedures but are relatively higher among donors who are older, are African American, and have select comorbid conditions. The increased risks for rehospitalizations among African Americans are not unique to living donation.
机译:背景和目标:2012年,活体捐献者占美国肾脏捐献者的43%。尽管研究表明捐献的长期影响极小,但针对该人群的综合纵向研究却很少。这项研究的主要目的是检查捐赠后再次住院的发生率,危险因素和原因。设计,设置,参与者和评估:由美国医疗保健研究与质量局(National Healthcare Healthcare and Quality)编制的州住院患者数据库(SID)用于确定2005年至2010年之间四个不同州的活体捐赠者(n = 4524)。使用多变量生存模型检查再次住院的风险,并将患者特征与来自移植接受者科学注册处(SRTR)的数据进行比较。比较了接受阑尾切除术(n = 200,274),胆囊切除术(n = 255,231)和肾切除术(非转移性癌)(n = 1314)患者的结果。结果:研究人群与美国捐助者相似(SRTR和SID分别为:平均年龄41岁和41岁;非裔美国人分别为12%和10%;女性分别为60%和61%)。捐赠后三年住院治疗的所有原因的发生率为11%,不包括妊娠相关住院的发生率为9%。在审查了与妊娠相关的住院治疗的模型后,发现年龄较大(调整后的危险比[AHR]为1.02 /年; 95%置信区间[95%CI]为1.01至1.03),非裔美国人(AHR为2.16; 95%CI ,1.54至3.03),抑郁症(AHR,1.88; 95%CI,1.12至3.14),甲状腺功能减退症(AHR,1.63; 95%CI,1.06至2.49)和更长的初始住院时间与更高的再住院率有关。与活体捐献者相比,接受阑尾切除术(AHR,1.58; 95%CI,1.42至1.75),胆囊切除术(AHR,2.25; 95%CI,2.03至2.50)和非转移性癌肾切除术的患者,再次住院的调整后风险更大。 AHR,2.95; 95%CI,2.58至3.37)。在每个外科手术组中,非洲裔美国人的再住院风险均高于白人。结论:SID是评估活体肾脏供体的特征和结果的宝贵资源,而传统移植数据库中没有这些信息。供体肾切除术后的再入院率比其他类似的外科手术要低,但在年龄较大,属于非裔美国人且有一定合并症的供体中相对较高。非裔美国人重新住院的风险增加并非生活捐赠所独有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号